Pre-order Enquiry
Request Free Sample
Global and United States ALK Positive Lung Cancer Treatment Market Report & Forecast 2022-2028
SKU ID : QYR-20747809 | Publishing Date : 19-Apr-2022 | No. of pages : 85
Detailed TOC of Global and United States ALK Positive Lung Cancer Treatment Market Report & Forecast 2022-2028
1 Study Coverage1.1 ALK Positive Lung Cancer Treatment Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global ALK Positive Lung Cancer Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global ALK Positive Lung Cancer Treatment Market Size for the Year 2017-2028
1.2.2 Global ALK Positive Lung Cancer Treatment Market Size for the Year 2017-2028
1.3 ALK Positive Lung Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States ALK Positive Lung Cancer Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of ALK Positive Lung Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 ALK Positive Lung Cancer Treatment Market Dynamics
1.4.1 ALK Positive Lung Cancer Treatment Industry Trends
1.4.2 ALK Positive Lung Cancer Treatment Market Drivers
1.4.3 ALK Positive Lung Cancer Treatment Market Challenges
1.4.4 ALK Positive Lung Cancer Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 ALK Positive Lung Cancer Treatment by Type
2.1 ALK Positive Lung Cancer Treatment Market Segment by Type
2.1.1 Crizotinib
2.1.2 Alectinib
2.1.3 Ceritinib
2.1.4 Brigatinib
2.1.5 Other
2.2 Global ALK Positive Lung Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global ALK Positive Lung Cancer Treatment Market Size by Type (2017-2028)
2.4 United States ALK Positive Lung Cancer Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States ALK Positive Lung Cancer Treatment Market Size by Type (2017-2028)
3 ALK Positive Lung Cancer Treatment by Application
3.1 ALK Positive Lung Cancer Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Other
3.2 Global ALK Positive Lung Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global ALK Positive Lung Cancer Treatment Market Size by Application (2017-2028)
3.4 United States ALK Positive Lung Cancer Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States ALK Positive Lung Cancer Treatment Market Size by Application (2017-2028)
4 Global ALK Positive Lung Cancer Treatment Competitor Landscape by Company
4.1 Global ALK Positive Lung Cancer Treatment Market Size by Company
4.1.1 Top Global ALK Positive Lung Cancer Treatment Companies Ranked by Revenue (2021)
4.1.2 Global ALK Positive Lung Cancer Treatment Revenue by Player (2017-2022)
4.2 Global ALK Positive Lung Cancer Treatment Concentration Ratio (CR)
4.2.1 ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of ALK Positive Lung Cancer Treatment in 2021
4.2.3 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global ALK Positive Lung Cancer Treatment Headquarters, Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global ALK Positive Lung Cancer Treatment Headquarters and Area Served
4.3.2 Global ALK Positive Lung Cancer Treatment Companies Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into ALK Positive Lung Cancer Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States ALK Positive Lung Cancer Treatment Market Size by Company
4.5.1 Top ALK Positive Lung Cancer Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States ALK Positive Lung Cancer Treatment Revenue by Players (2020, 2021 & 2022)
5 Global ALK Positive Lung Cancer Treatment Market Size by Region
5.1 Global ALK Positive Lung Cancer Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global ALK Positive Lung Cancer Treatment Market Size by Region (2017-2028)
5.2.1 Global ALK Positive Lung Cancer Treatment Market Size by Region: 2017-2022
5.2.2 Global ALK Positive Lung Cancer Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America ALK Positive Lung Cancer Treatment Market Size YoY Growth 2017-2028
6.1.2 North America ALK Positive Lung Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific ALK Positive Lung Cancer Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific ALK Positive Lung Cancer Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe ALK Positive Lung Cancer Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe ALK Positive Lung Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America ALK Positive Lung Cancer Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America ALK Positive Lung Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa ALK Positive Lung Cancer Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa ALK Positive Lung Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Details
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
7.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.1.5 F. Hoffmann-La Roche Recent Development
7.2 Pfizer
7.2.1 Pfizer Company Details
7.2.2 Pfizer Business Overview
7.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
7.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.2.5 Pfizer Recent Development
7.3 Novartis
7.3.1 Novartis Company Details
7.3.2 Novartis Business Overview
7.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
7.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.3.5 Novartis Recent Development
7.4 TP Therapeutics
7.4.1 TP Therapeutics Company Details
7.4.2 TP Therapeutics Business Overview
7.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
7.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.4.5 TP Therapeutics Recent Development
7.5 Bristol-Myers Squibb
7.5.1 Bristol-Myers Squibb Company Details
7.5.2 Bristol-Myers Squibb Business Overview
7.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
7.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.5.5 Bristol-Myers Squibb Recent Development
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Company Details
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
7.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.6.5 Eli Lilly and Company Recent Development
7.7 Takeda
7.7.1 Takeda Company Details
7.7.2 Takeda Business Overview
7.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
7.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.7.5 Takeda Recent Development
7.8 Beacon Pharma
7.8.1 Beacon Pharma Company Details
7.8.2 Beacon Pharma Business Overview
7.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
7.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022)
7.8.5 Beacon Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States ALK Positive Lung Cancer Treatment Market Report & Forecast 2022-2028
List of TablesTable 1. ALK Positive Lung Cancer Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. ALK Positive Lung Cancer Treatment Market Trends
Table 3. ALK Positive Lung Cancer Treatment Market Drivers
Table 4. ALK Positive Lung Cancer Treatment Market Challenges
Table 5. ALK Positive Lung Cancer Treatment Market Restraints
Table 6. Global ALK Positive Lung Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States ALK Positive Lung Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global ALK Positive Lung Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States ALK Positive Lung Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top ALK Positive Lung Cancer Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global ALK Positive Lung Cancer Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global ALK Positive Lung Cancer Treatment Revenue Share by Player, 2017-2022
Table 13. Global ALK Positive Lung Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global ALK Positive Lung Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ALK Positive Lung Cancer Treatment as of 2021)
Table 15. Top Players of ALK Positive Lung Cancer Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into ALK Positive Lung Cancer Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top ALK Positive Lung Cancer Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States ALK Positive Lung Cancer Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States ALK Positive Lung Cancer Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global ALK Positive Lung Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global ALK Positive Lung Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global ALK Positive Lung Cancer Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America ALK Positive Lung Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific ALK Positive Lung Cancer Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe ALK Positive Lung Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa ALK Positive Lung Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa ALK Positive Lung Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. F. Hoffmann-La Roche Company Details
Table 31. F. Hoffmann-La Roche Business Overview
Table 32. F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Product
Table 33. F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 34. F. Hoffmann-La Roche Recent Development
Table 35. Pfizer Company Details
Table 36. Pfizer Business Overview
Table 37. Pfizer ALK Positive Lung Cancer Treatment Product
Table 38. Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 39. Pfizer Recent Development
Table 40. Novartis Company Details
Table 41. Novartis Business Overview
Table 42. Novartis ALK Positive Lung Cancer Treatment Product
Table 43. Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 44. Novartis Recent Development
Table 45. TP Therapeutics Company Details
Table 46. TP Therapeutics Business Overview
Table 47. TP Therapeutics ALK Positive Lung Cancer Treatment Product
Table 48. TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 49. TP Therapeutics Recent Development
Table 50. Bristol-Myers Squibb Company Details
Table 51. Bristol-Myers Squibb Business Overview
Table 52. Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Product
Table 53. Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Recent Development
Table 55. Eli Lilly and Company Company Details
Table 56. Eli Lilly and Company Business Overview
Table 57. Eli Lilly and Company ALK Positive Lung Cancer Treatment Product
Table 58. Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 59. Eli Lilly and Company Recent Development
Table 60. Takeda Company Details
Table 61. Takeda Business Overview
Table 62. Takeda ALK Positive Lung Cancer Treatment Product
Table 63. Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 64. Takeda Recent Development
Table 65. Beacon Pharma Company Details
Table 66. Beacon Pharma Business Overview
Table 67. Beacon Pharma ALK Positive Lung Cancer Treatment Product
Table 68. Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2017-2022) & (US$ Million)
Table 69. Beacon Pharma Recent Development
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
List of Figures
Figure 1. ALK Positive Lung Cancer Treatment Product Picture
Figure 2. Global ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global ALK Positive Lung Cancer Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States ALK Positive Lung Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States ALK Positive Lung Cancer Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States ALK Positive Lung Cancer Treatment Market Share in Global 2017-2028
Figure 7. ALK Positive Lung Cancer Treatment Report Years Considered
Figure 8. Product Picture of Crizotinib
Figure 9. Product Picture of Alectinib
Figure 10. Product Picture of Ceritinib
Figure 11. Product Picture of Brigatinib
Figure 12. Product Picture of Other
Figure 13. Global ALK Positive Lung Cancer Treatment Market Share by Type in 2022 & 2028
Figure 14. Global ALK Positive Lung Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
Figure 16. United States ALK Positive Lung Cancer Treatment Market Share by Type in 2022 & 2028
Figure 17. United States ALK Positive Lung Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States ALK Positive Lung Cancer Treatment Market Share by Type (2017-2028)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Other
Figure 22. Global ALK Positive Lung Cancer Treatment Market Share by Application in 2022 & 2028
Figure 23. Global ALK Positive Lung Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
Figure 25. United States ALK Positive Lung Cancer Treatment Market Share by Application in 2022 & 2028
Figure 26. United States ALK Positive Lung Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States ALK Positive Lung Cancer Treatment Market Share by Application (2017-2028)
Figure 28. North America ALK Positive Lung Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe ALK Positive Lung Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific ALK Positive Lung Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America ALK Positive Lung Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa ALK Positive Lung Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E ALK Positive Lung Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. F. Hoffmann-La Roche Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 58. Novartis Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 59. TP Therapeutics Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 61. Eli Lilly and Company Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 62. Takeda Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 63. Beacon Pharma Revenue Growth Rate in ALK Positive Lung Cancer Treatment Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Keyplayers in Global and United States ALK Positive Lung Cancer Treatment Market Report & Forecast 2022-2028
F. Hoffmann-La RochePfizer
Novartis
TP Therapeutics
Bristol-Myers Squibb
Eli Lilly and Company
Takeda
Beacon Pharma
Request Sample
Request Discount
